Biblio

Author Title [ Type

] Year

Filters: Author is Kaneko, Shin [Clear All Filters]

Journal Article

Kanie K, Kaneko S. [Basic Research and Clinical Development of Regenerative Immunotherapy Using iPS Cells]. Gan To Kagaku Ryoho. 2023;50(5):571-576.

Io S, Kabata M, Iemura Y, Semi K, Morone N, Minagawa A, Wang B, Okamoto I, Nakamura T, Kojima Y, et al. Capturing human trophoblast development with naive pluripotent stem cells in vitro. Cell Stem Cell. 2021.

Hirata S, Takayama N, Jono-Ohnishi R, Endo H, Nakamura S, Dohda T, Nishi M, Hamazaki Y, Ishii E-I, Kaneko S, et al. Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling. J Clin Invest. 2013.

Kaneko S. [Development of CAR-T cell therapy using allogeneic iPS cells]. Rinsho Ketsueki. 2022;63(10):1454-1460.

Bae J, Kitayama S, Herbert Z, Daheron L, Kurata K, Keskin D, Livak K, Li S, Tarannum M, Romee R, et al. Differentiation of BCMA-specific induced pluripotent stem cells into CD8ab+ T cells targeting myeloma. Blood. 2023.

Tanaka M, Iwamoto Y, Wang B, Imai E, Yoshida M, Iriguchi S, Kaneko S. Effective and stable gene transduction in rhesus macaque iPSCs capable of T-lineage differentiation utilizing the piggyBac system. Regen Ther. 2024;27:104-111.

Flahou C, Morishima T, Higashi N, Hayashi Y, Xu H, Wang B, Zhang C, Ninomiya A, Qiu W-Y, Yuzuriha A, et al. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells. Biochem Biophys Res Commun. 2023;662:76-83.

Radulovic V, van der Garde M, Koide S, Sigurdsson V, Lang S, Kaneko S, Miharada K. Junctional Adhesion Molecule 2 Represents a Subset of Hematopoietic Stem Cells with Enhanced Potential for T Lymphopoiesis. Cell Rep. 2019;27(10):2826-2836.e5.

Takayanagi S-I, Wang B, Hasegawa S, Nishikawa S, Fukumoto K, Nakano K, Chuganji S, Kato Y, Kamibayashi S, Minagawa A, et al. Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells. Mol Ther Methods Clin Dev. 2023;31:101109.

Ueda T, Shiina S, Iriguchi S, Terakura S, Kawai Y, Kabai R, Sakamoto S, Watanabe A, Ohara K, Wang B, et al. Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Nat Biomed Eng. 2022.

Lee S, Huh JYoung, Turner DM, Lee S, Robinson J, Stein JE, Shim SHan, Hong CPyo, Kang MSeo, Nakagawa M, et al. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations. Stem Cells. 2018.

Tsuchiya N, Zhang R, Iwama T, Ueda N, Liu T, Tatsumi M, Sasaki Y, Shimoda R, Osako Y, Sawada Y, et al. Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1 Dendritic Cells. Cell Rep. 2019;29(1):162-175.e9.